Cite
HARVARD Citation
Murai, K. et al. (n.d.). A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia‐chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria. European journal of haematology. pp. 558-565. [Online].